Drug safety debates focus on proposed changes to FDA

06/5/2007 | Forbes

The drug safety debate has attracted doctors, lawyers and legislators to comment on FDA operations and proposed legislation to reform the agency. The drug industry supports the Kennedy-Enzi bill requiring more transparency for clinical trials and giving FDA added authority to change drug labels and require post-market studies. Others are calling for a separate center to monitor drugs on the market or a reformed budget to lessen industry ties.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA